Tuesday , October 17 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 21)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

dave

It appears that we are now looking more and more at diabetes as a cardiovascular risk factor, and our therapies and goals for diabetes care need to be targeted in that direction. In order to help make this message as clear as possible, we have focused our homerun slides and ...

Read More »

January 30, 2016

dave

I did a quick search, and in the past 2 years we have had over 80 items on food choices and the best way to eat for diabetes. This does not even begin to include the ones we turned down. Often these ideas conflict, and experts flip-flop on what works best ...

Read More »

dave

It is very frustrating when we take our time to educate patients on the complications of diabetes and then they flat out ignore us. These patients usually don’t have symptoms that make them feel bad, and so they feel we are overreacting and don’t really listen or make changes. Usually ...

Read More »

January 16, 2016

dave

I was traveling this past week and it seemed that almost every person was wearing some kind of fitness tracking device. As I was going through the Atlanta airport, I watched people checking their devices and commenting on their steps while they were walking underground between terminals. When I sat on the plane, ...

Read More »

dave

It has been a few years since Dr. Steven Nissan shook the diabetes world apart with his scathing review of the TZDs, pioglitazone and rosiglitizone. Many professionals blame him for the demise of rosiglitizone and the almost-death of pioglitazone, because of his comments on heart problems caused by the class ...

Read More »

January 9, 2016

This week CES (Consumer Electronics Show) is in full swing in Las Vegas. There are over 180,000 attendees, and over the next four days they will look at more than 10,000 displays of products for home, auto, industrial and personal use. When we were there 3 years ago there was one ...

Read More »

dave

For thousands of years humans had to adapt to their conditions. We were affected by heat and cold, severe weather events, and times of feast or famine. We became good at adapting to our environments, and our bodies learned mechanisms to carry us through almost any condition. During these millennia ...

Read More »

January 2, 2016

dave

Happy New Year! Now that the last leftovers of the holidays are gone and the last big party of the season is over, our patients will make resolutions to eat better, lose weight, exercise more and lower their A1c’s. There will be at least 100 new commercials, YouTube videos, and ...

Read More »

dave

When you look at the history of diabetes medication development, it appears every new class of drugs is based on finding a part of the body that is failing or malfunctioning, and then finding a way to rectify it. Insulin came first because that was missing in type one patients. ...

Read More »

As we finish up the holiday season and everyone gets ready to set their New Year’s resolutions, there is no doubt that this is the most stressful time of the year. Many of our patients seem to have their worst control around the holidays. This is usually 100% blamed on ...

Read More »